Navigation Links
Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:6/3/2010

RCC), solid tumors, non small cell lung cancer (NSCLC) and selected hematologic malignancies such as leukemia.

PARP Inhibitors (veliparib) – Veliparib is an oral PARP-inhibitor that was discovered and developed by Abbott researchers to prevent DNA repair in cancer cells and increase the effectiveness of common DNA-damaging therapies like chemotherapy or radiation. Veliparib is currently being studied in more than a dozen cancers and tumor types, including Phase II studies in melanoma and breast cancer. Veliparib is also being studied in the I-SPY 2 breast cancer trial, led by the Foundation for the National Institutes of Health.

Bcl-2 Family Protein Inhibitors (navitoclax) – Navitoclax restores apoptosis or programmed cell death, a natural mechanism for the elimination of cancerous cells, by inhibiting the function of Bcl-2 proteins. Bcl-2 regulates apoptosis, as well as tumor formation and tumor growth, and can enable cancer cells to resistance to treatment. Navitoclax is in clinical trials for lymphomas and solid tumors, including small cell lung cancer. Additionally, preclinical data have shown that Bcl-2 family protein inhibitors have the potential to enhance the effects of chemotherapy and radiation used to treat other types of cancer, such as non-small cell lung cancer.

Elotuzumab (HuLuc63) – Elotuzumab is a humanized monoclonal antibody that binds to CS1, a cell-surface glycoprotein that is highly expressed on myeloma cells but minimally expressed on normal human cells. Abbott is developing elotuzumab for multiple myeloma in collaboration with Bristol-Myers Squibb Company.

Beyond pharmaceutical research, Abbott provides supportive care products and diagnostics related to oncology. The company offers a broad range of pharmaceutical and nutritional products to help people living with cancer, inclu
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
2. Abbotts Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
3. Abbotts Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
4. New Data Reinforces Safety Profile of Abbotts Market-Leading XIENCE V(R) Drug Eluting Stent
5. Assegai Wins Big Settlement Against ABBOTTs Subsidiary
6. Abbott 2009 Global Citizenship Report Highlights Companys Progress in Redefining Responsibility
7. Abbott Chairman and CEO Miles D. White to Present at Sanford Bernstein Strategic Decisions Conference
8. Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010
9. Abbott Completes Acquisition of Facet Biotech
10. Abbott Completes Acquisition of STARLIMS Technologies
11. Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... HILL, N.C. , May 22, 2015 /PRNewswire/ ... be hosting its sixth Medical Affairs ... 12:30PM (EDT) via a virtual roundtable to discuss ... Research." Best Practices, Medical Affairs Consortium ... sharing insights about the key challenges they face. ...
(Date:5/22/2015)... 2015 /CNW/ - The Taskforce representing Canada,s ... the hard work that the Minister and Health Canada have ... program recognizes the needs of the thalidomide survivors, and more ... year, tax free, with annual adjustments for inflation. ... payments of $100,000 based on the severity of their disability, ...
(Date:5/22/2015)... , May 22, 2015  Amgen (NASDAQ: ... has commenced termination of its participation in ... AstraZeneca (LON:AZN, STO:AZN and NYSE: AZN ... in development for patients with moderate-to-severe plaque ... decision was based on events of suicidal ...
Breaking Medicine Technology:Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5
... Young Innovations, Inc. (Nasdaq: YDNT ) today announced that it will broadcast ... call on Wednesday, July 21, 2010 at 11:00 a.m. Central ... InterCall at http://tinyurl.com/yiq210 . Access to the live audio broadcast will also ... , , ...
... Ill. , July 14 RoundTable Healthcare ... the health-care industry, announced today that it has entered ... portfolio companies, Bioniche Pharma Holdings Limited ("Bioniche Pharma") to ... pharmaceutical company, for $550 million in cash. ...
Cached Medicine Technology:Young Innovations, Inc. Provides 2nd Quarter Conference Call Details 2RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc. 2RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc. 3
(Date:5/24/2015)... NH (PRWEB) May 24, 2015 ... leather, launches “InkGard™ Plus” – a classic, rugged ... the polymer allowing difficult stains, including ink, to ... 16 different colors suitable for corporate, healthcare, hospitality ... in line with EnviroLeather’s goal of developing products ...
(Date:5/24/2015)... WI (PRWEB) May 24, 2015 ... Health System CEO - The ... and honored at the fourth annual ... April 15 at Geneva National in ... school): ,     -Badger High School,         Jonathan ...
(Date:5/23/2015)... 23, 2015 With the implementation of ... finding it increasingly difficult to provide their employees with ... provide adequate insurance for employees stand to face strict ... an integral part of a business’s success or failure. ... businesses, Online USA Doctors has created a varying level ...
(Date:5/23/2015)... 23, 2015 Javon Bea Mercy ... Sports Medicine and Rehabilitation Center, 557 N. Washington St., ... June 1-July 20, 5:30-6:30 pm. , The 8-week clinic ... Laurie Finke, RN, BSN, who will offer training that ... nutrition, running mechanics and show selection and weekly training ...
(Date:5/22/2015)... CA (PRWEB) May 22, 2015 The ... two exciting events in June. They will hold a ... Doctorate and a two-day class on Classical Chinese Medicine. ... June 3, Dr. Steve Given, the Dean of Clinical ... discuss the new First Professional Doctorate program. ACTCM is ...
Breaking Medicine News(10 mins):Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:ACTCM Announces Upcoming June Events 2
... and external ... pediatric heart pumps, PITTSBURGH, April 3, ... in the use of lifesaving,ventricular assist devices (VADs) for children in ... awarded a $2.3 million grant from,the National Institutes of Health (NIH) ...
... Angeles Focuses on the Impact of the ... Environment on Public Health, LOS ANGELES, April ... off National Public Health Week today,with a press conference held outside the ... "Healthy People:,Healthy Planet - Climate Change in LA". It focuses on the ...
... M. Bradley Receives Top Recognition as Titan of Business & ... ... WASHINGTON, April 3, 2008 Washington DC,business community leaders ... Leukemia Ball. Drawing over 2,500 guests,to the Washington Convention Center ...
... YORK (April 3, 2008) -- Dr. John A. Clements ... recognition of his seminal contributions to our understanding of ... a lifesaving treatment for respiratory distress syndrome (RDS) in ... neonatal RDS now causes very few deaths. , The ...
... 2008 Although sexual dysfunction in some men is ... examined in women. In an article published in the ... researchers found no increased prevalence or incidence of cardiovascular ... dissatisfied with their sexual activity. , Researchers from Boston ...
... The American Heart Associations Los Angeles Division today ... the paramedic model in use around the country and ... Research Institute at Harbor-UCLA Medical Center (LA BioMed). , ... Awards to Dr. Criley and William Koenig, Los Angeles ...
Cached Medicine News:Health News:Children's Hospital of Pittsburgh of UPMC Involved in Projects To Develop Nation's First Heart Assist Devices for Young Children 2Health News:Children's Hospital of Pittsburgh of UPMC Involved in Projects To Develop Nation's First Heart Assist Devices for Young Children 3Health News:Healthy People: Healthy Planet - Climate Change in LA 2Health News:Healthy People: Healthy Planet - Climate Change in LA 3Health News:DC's Business Leaders Raise $3.3 Million at Annual Leukemia Ball Featuring Jay Leno 2Health News:DC's Business Leaders Raise $3.3 Million at Annual Leukemia Ball Featuring Jay Leno 3Health News:DC's Business Leaders Raise $3.3 Million at Annual Leukemia Ball Featuring Jay Leno 4Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 2Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 3Health News:Pollin Pediatric Research Prize awarded for discovery of lifesaving treatment of RDS 4Health News:Sexual dissatisfaction in postmenopausal women not linked to cardiovascular disease 2Health News:Pioneer of paramedic model to be honored 2Health News:Pioneer of paramedic model to be honored 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: